Latest Reports

  • Research on China Heparin Industry, 2015

    Published in ; US $ 2000 Onwards; Publisher: Chisult Insight

    Currently there are 4 major productss in the global low molecular heparin preparation market: SNY’s enoxaparin sodium, Pfizer’s dalteparin sodium, GSK’s nadroparin calcium and LEO’s tinzaparin sodium. Among which, enoxaparin remains the best –selling product even though its sales amount continued to decline in recent years. Though enoxaparin always dominates the international heparin preparation... 
  • Global LVAD Market Report: 2015 Edition

    Published in ; US $ 800 Onwards; Publisher: Koncept Analytics

    Left ventricular assist devices (LVADs) are mechanical heart pumps used to support a failing heart in patients with advanced heart failure. LVADs are lifesaving modules for patients who need temporary cardiac assistance and for those waiting for heart transplantation. They are used in the bridge-to-transplantation (BTT), destination therapy (DT) and bridge to recovery. LVAD is a key potential area... 
  • Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) – Forecast to 2020

    Published in ; US $ 4650 Onwards; Publisher: MarketsandMarkets

    Diabetes is a group of metabolic disorders, characterized by high blood glucose levels due to either inadequate insulin production or insulin resistance. Diabetes care devices are used to manage blood glucose levels. There are mainly two types of diabetes care devices, namely, blood glucose monitoring devices and insulin delivery devices. The BRIC diabetes care devices market is largely driven by the... 
  • Uganda Pharmaceuticals and Healthcare Report Q4 2015

    Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

    BMI View: Uganda’s pharmaceutical market remains dampened by poor funding and consequently underdevelopment. The private sector makes up the clear majority of pharmaceutical spending in the country in terms of value and strong private consumption growth will drive medicine spending further in this regard. Opportunities will be present for those multinationals involved in the selling of high-value patented...